Merck & Co Inc (MRK)
84.89
+0.34 +0.40%
NYSE
Nov 15, 16:27
Delayed 2m
USD
Merck Cash from Investing (TTM):
312.00M for Sept. 30, 2019View 4,000+ financial data types
Browse...
View Full Chart
Cash from Investing (TTM) Chart
Export Data
Save Image
Print Image
For advanced charting, view our full-featured
Fundamental Chart
Historical Cash from Investing (TTM) Data
View and export this data going back to 1984.
Start your Free Trial
Export Data
Date Range:
| Data for this Date Range | |
|---|---|
| Sept. 30, 2019 | 312.00M |
| June 30, 2019 | 1.781B |
| March 31, 2019 | 4.879B |
| Dec. 31, 2018 | 4.314B |
| Sept. 30, 2018 | 2.078B |
| June 30, 2018 | 1.089B |
| March 31, 2018 | -711.00M |
| Dec. 31, 2017 | 2.679B |
| Sept. 30, 2017 | 174.00M |
| June 30, 2017 | -1.387B |
| March 31, 2017 | -1.758B |
| Dec. 31, 2016 | -3.21B |
| Sept. 30, 2016 | -1.264B |
| June 30, 2016 | -435.00M |
| March 31, 2016 | 3.588B |
| Dec. 31, 2015 | -4.758B |
| Sept. 30, 2015 | 3.063B |
| June 30, 2015 | -598.00M |
| March 31, 2015 | -3.172B |
| Dec. 31, 2014 | -374.00M |
| Sept. 30, 2014 | -6.401B |
| June 30, 2014 | -4.716B |
| March 31, 2014 | -5.802B |
| Dec. 31, 2013 | -3.148B |
| Sept. 30, 2013 | -8.723B |
| June 30, 2013 | -8.525B |
| March 31, 2013 | -7.688B |
| Dec. 31, 2012 | -6.805B |
| Sept. 30, 2012 | -4.091B |
| June 30, 2012 | -2.515B |
| March 31, 2012 | -3.265B |
| Dec. 31, 2011 | -2.89B |
| Sept. 30, 2011 | -2.213B |
| June 30, 2011 | -1.756B |
| March 31, 2011 | -244.00M |
| Dec. 31, 2010 | -3.497B |
| Sept. 30, 2010 | -15.35B |
| June 30, 2010 | -3.537B |
| March 31, 2010 | -1.382B |
| Dec. 31, 2009 | 3.156B |
| Sept. 30, 2009 | 15.57B |
| June 30, 2009 | 281.10M |
| March 31, 2009 | -2.347B |
| Dec. 31, 2008 | -1.834B |
| Sept. 30, 2008 | -2.232B |
| June 30, 2008 | 975.80M |
| March 31, 2008 | 374.20M |
| Dec. 31, 2007 | -2.81B |
| Sept. 30, 2007 | -3.656B |
| June 30, 2007 | -5.554B |
There is no data for the selected date range.
An error occurred. Please try again by refreshing your browser or contact us with details of your problem.
About Cash From Investing
An item on a company's cash flow statement. Lists aggregate change in cash position resulting from investing activities. Includes the company's cash inflows and outflows from investments in financial markets and the sale of capital assets.
Learn More
Advertisement
Cash from Investing (TTM) Benchmarks
| Benchmarks | |
|---|---|
| Abbott Laboratories | -1.822B |
| Amgen Inc | 7.035B |
| Biogen Inc | -1.863B |
Cash from Investing (TTM) Range, Past 5 Years
| Minimum | -4.758B | Dec 2015 |
| Maximum | 4.879B | Mar 2019 |
| Average | 314.50M |
News
Sector Update: Leading Health Care Stocks Mixed In Friday's Pre-Bell Trading
MT Newswires 11/15 09:14 ET
MT Newswires 11/15 09:14 ET
Merck Animal Health's Bravecto Plus Parasite Treatment For Cats Wins FDA Approval
MT Newswires 11/15 07:34 ET
MT Newswires 11/15 07:34 ET
Advertisement
